Meeting Banner
Abstract #3351

Role of PET and ASL simultaneously acquired imaging biomarkers in differentiating progression from radionecrosis in glial brain tumors

Nadya Pyatigorskaya1, Arnaud Pellerin2, Maya Kalife3, Laura Rozenblum-Beddok4, Marc Bertaux2, Marine Soret2, Lydia Yahia-cherif3, and Aurélie Kas2
1CENIR, ICM, Paris, France, 2Pitié-Salpêtrière Hospital, APHP, Sorbonne universite, Paris, France, 3ICM, Paris, France, 4Pitié Salpêtrière, APHP, Paris, France

Synopsis

We aimed at investigating the methods based on coupling of of amino-acid metabolism (18F-DOPA-PET) measurements and cerebral blood flow (CBF) maps to evaluate the diagnostic performance of PET/MRI in glioma imaging. Tumor isocontour maps and T-maps were created using SPM and metabolic/perfusion abnormalities were evaluated with the asymmetry index z-score. SPM map analysis of significant-size clusters and semi-quantitative evaluation were performed and compared to gold standard diagnosis. Both the tumor isocontour maps and T-maps showed the highest specificity for ASL and sensitivity for 18F-DOPA analysis, allowing high diagnostic performance in differentiating between progression and radionecrosis particularly in high-grade treated gliomas.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.

Keywords